Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Rangering i aksjer #40
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Aksjekurs
$481.73
Markedsverdi
$377.65B
Endring (1 dag)
-0.96%
Endring (1 år)
50.07%
Land
CH
Handel Roche Holding AG (RO)

Kategori

Inntekter for Roche Holding AG (RO)
Inntekter i Dec 2025 TTM: $77.52B
Ifølge de nyeste økonomiske rapportene til Roche Holding AG er selskapets nåværende inntekter (TTM) $77.52B. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Roche Holding AG fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$79.67B 2.77%
US
$97.93B 26.33%
US
$64.39B -16.94%
US
$66.40B -14.34%
US
$56.26B -27.43%
CH